Priligy 30 mg: Price, Availability & U.S. Status
Priligy 30 mg is a branded dapoxetine film-coated tablet used for premature ejaculation in markets where the product is authorized. Current French public medicine records list PRILIGY 30 mg as a valid prescription-only medicine containing dapoxetine, with Phoenix Labs Unlimited Company as the marketing-authorization holder and Menarini - Von Heyden GmbH as manufacturer. The U.S. regulatory situation is different: FDA states that dapoxetine is not an FDA-approved active ingredient.
Priligy 30 product identity
Current French product information identifies each Priligy 30 mg film-coated tablet as containing dapoxetine hydrochloride equivalent to 30 mg dapoxetine. The tablet is described as light grey, round and film-coated. The same public database lists the product authorization as valid and prescription-only.
The French record identifies Phoenix Labs Unlimited Company as the marketing-authorization holder and Menarini - Von Heyden GmbH in Dresden, Germany, as manufacturer. Other countries can have different authorization holders or distributors, so those commercial roles should be checked against the local pack and regulator record.
Priligy versus dapoxetine
Dapoxetine is the active ingredient; Priligy is a specific brand. European regulator materials document Priligy 30 mg and 60 mg film-coated tablets for premature ejaculation in adult men under market-specific authorizations. That does not create a U.S. approval.
FDA has explicitly described dapoxetine as an active ingredient not approved by FDA. Therefore a Priligy pack authorized in France, Ireland or another non-U.S. market should not be represented as an FDA-approved U.S. prescription product.
Prescription and market status
Priligy is prescription-only in the current French public medicines database, and Ireland's regulator also lists Priligy 30 mg as an authorized prescription medicine. Availability and the legal supply route can differ by country even when the same brand name is used.
For a U.S. reader, the key point is that dapoxetine is not FDA-approved. An online listing offering “Priligy 30 mg” to U.S. buyers therefore does not become an approved U.S. pharmacy product simply because the medicine has a legitimate authorization elsewhere.
Priligy price and availability questions
Priligy can have a normal regulated pharmacy market in countries where it is authorized, but that does not translate into a standard U.S. retail price. Price comparisons should identify the country, package size, prescription rules and legal supply channel before comparing offers.
When researching availability, confirm that the product is authorized in the relevant jurisdiction, that the pharmacy is licensed, and that the package identifies the correct marketing-authorization holder/manufacturer for that market. Davidson Pharmacy's inventory, price, online dispensing or shipping availability for Priligy is not claimed here.
What to verify before obtaining a dapoxetine product
- Confirm that the product is specifically Priligy 30 mg and contains dapoxetine at the labeled strength.
- Check the country-specific authorization, prescription requirement and manufacturer/authorization-holder details.
- Do not assume that a foreign authorization means FDA approval in the United States.
- Review contraindications and interactions with a prescriber or pharmacist. Dapoxetine is an SSRI, and official product information includes important interaction restrictions and warnings about syncope/fainting.
- Use the current patient leaflet and package rather than relying on old reseller descriptions.
Related Davidson men's-health medication guides
Priligy belongs to a different active-ingredient category from the sildenafil and tadalafil products on this site, so forced brand-to-brand comparisons are not useful. For the broader commercial research structure, return to the Men's Health Prescription Medication Guide.
Research sources
Current Priligy product identity and manufacturer information is based on public regulator records. The U.S. status statement is based on FDA's explicit description of dapoxetine as not approved by FDA.
- French Public Medicines Database — PRILIGY 30 mg, valid authorization, prescription-only status, active ingredient, marketing-authorization holder and manufacturer
- Health Products Regulatory Authority (Ireland) — Priligy 30 mg authorization and prescription status
- European Medicines Agency — Priligy referral assessment report
- U.S. FDA — dapoxetine identified as an active ingredient not approved by FDA
- Malaysian National Pharmaceutical Regulatory Agency — PRILIGY 30 MG product record, dapoxetine hydrochloride and Menarini - Von Heyden GmbH manufacturing record